Does EFTRENONACOG ALFA Cause Poor venous access? 28 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Poor venous access have been filed in association with EFTRENONACOG ALFA. This represents 1.3% of all adverse event reports for EFTRENONACOG ALFA.
28
Reports of Poor venous access with EFTRENONACOG ALFA
1.3%
of all EFTRENONACOG ALFA reports
0
Deaths
10
Hospitalizations
How Dangerous Is Poor venous access From EFTRENONACOG ALFA?
Of the 28 reports, 10 (35.7%) required hospitalization.
Is Poor venous access Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EFTRENONACOG ALFA. However, 28 reports have been filed with the FAERS database.
What Other Side Effects Does EFTRENONACOG ALFA Cause?
Haemorrhage (802)
Haemarthrosis (196)
Fall (151)
Contusion (108)
Arthralgia (104)
Traumatic haemorrhage (93)
Limb injury (83)
Head injury (76)
Epistaxis (73)
Spontaneous haemorrhage (71)
What Other Drugs Cause Poor venous access?
VEDOLIZUMAB (1,043)
INFLIXIMAB (917)
INFLIXIMAB-DYYB (782)
ECULIZUMAB (555)
HUMAN IMMUNOGLOBULIN G (504)
NATALIZUMAB (422)
RITUXIMAB (299)
TOCILIZUMAB (287)
METHOTREXATE (257)
ABATACEPT (249)
Which EFTRENONACOG ALFA Alternatives Have Lower Poor venous access Risk?
EFTRENONACOG ALFA vs EGG PHOSPHOLIPIDS\GLYCERIN\MEDIUM-CHAIN TRIGLYCERIDES\SOYBEAN OIL
EFTRENONACOG ALFA vs EGG PHOSPHOLIPIDS\GLYCERIN\SOYBEAN OIL
EFTRENONACOG ALFA vs EGG PHOSPHOLIPIDS\SAFFLOWER OIL\SOYBEAN OIL
EFTRENONACOG ALFA vs ELACESTRANT
EFTRENONACOG ALFA vs ELAFIBRANOR